Clinical Trial: Galantamine in the Treatment of Post-Traumatic Headache
Study Status: Recruiting
Recruit Status: Unknown status
Study Type: Interventional
Official Title: Galantamine in the Preventive Treatment of Chronic Post-Traumatic Headache
Brief Summary: Most patients with CPTH present with additional major cognitive, behavioral and somatic problems. Most drugs used currently have a negative influence on cognition. Therefore, treatment strategies addressing both the headache and cognitive disturbances in patients with CPTH are necessary. (CPTH; Chronic Post Traumatic Headache).
Detailed Summary: Headache is the most common symptom after a closed head injury, persisting for more then 2 months in 60% of the patients. CPTH is an important cause of consultations in neurology offices and headache clinics, posing a severe burden and affecting the quality of life of sufferers.
Sponsor: Rapoport, Alan, M.D.
Current Primary Outcome: Primary Headache Efficacy Measure; number of pain free days after 3 months
Original Primary Outcome: Same as current
Current Secondary Outcome:
- Consumption of rescue medication
- Number of days with moderate or severe headache after 3 months.
Original Secondary Outcome: Same as current
Information By: Rapoport, Alan, M.D.
Dates:
Date Received: September 13, 2005
Date Started: July 2005
Date Completion: August 2005
Last Updated: September 13, 2005
Last Verified: September 2005
